Week 545 Review - Best week for ages with decent rises across the portfolio.

What a week! Big rises across much of the portfolio meant the deficit between cost and value narrowed by £4,636 to £133,609 and the deficit between injection and value dropped to £50,073. Total portfolio value increased to £132,445.

Worst performer was SBTX:SkinBioTherapeutics, which dropped 10% after a massive rise last week. I think it was just a bit of profit taking, so hopefully it will recover next week.

The only other big loser was PAGE:Pagegroup after another lackluster trading statement sent the price down 8% and my holding is now 59% down. I won't be averaging down any time soon, but I will hold and average down if it starts creeping up for any length of time.

RIO:Rio Tinto went up 5%. I think it would have been more given the rises in other miners, but investors are spooked by the proposed merger with GLEN:Glencore. I did buy some more this week and it is now one of my larger holdings.

FDM:FDM Group is another of my poor performing magic formula shares, but went up 6% this week. My holding is 58% down and making a potential loss of £644, but they are suffering exactly the same malaise as PAGE:Pagegroup, as people are not hiring staff. I will keep an eye on these as a potential opportunity to average down if they continue to creep upwards.

AFC:AFC Energy have had a storming few weeks and went up another 7% this week. My holding is only down by 19% and making a potential loss of £390 but I have high hopes for a turnaround and significant re-rate.

FOUR:4imprint collapsed last year after a back-hand remark about the uncertainty of tariffs, so I doubled my holding and reduced my average price from around 5400p to 4084p. I'm glad I did, because they went up another 7% this week and my enlarged holding went 7% into profit with a potential £149, but I will be holding for a long time.

I recently bought back into III:3i Group after a significant drop in share price as investors were spooked that they couldn't continue their rate of growth. The 7% increase this week means my shares are 5% in profit. The profit is only £21 because I've only added £443 of shares so far in my monthly investments.

OPTI:Optibiotix finally had an up week, climbing 7%. Although I desperately hope last week was the lowest point, there's no sign of anything that will trigger sustained growth, with SweetBiotix product launch nowhere in sight. My paper loss is £101,374 on this share alone. I bet on the wrong pony and if it doesn't turn around then I've wasted most of what I've done for the last 10 years. It's been a harsh lesson in avoiding going big on a startup company with breakthrough but unproven products.

My other huge holding JLP:Jubilee Metals also had a good week, climbing 8%. My paper losses are still £14,371 but at least this one has real prospects of large profits in the next 12 months, so I am hopeful for recovery. I won't be buying any more though.

N91:Ninety One went up another 8% this week after a positive assets under management statement. My holding is up 25% and making £255 potential profit.

IPX:Impax Asset Management have had an utterly miserable time of late, but may have bounced off the bottom now, as they climbed 9% this week. My holdings are down 64% and 16% and making a combined paper loss of £1,465 but if they continue to rise I'll average down.

GGP:Greatland Resources is unstoppable. I bought more this week and they went up 10%. The purchase reduced my gains from over 100% to 69%, with potential profit at £1,619.

RAT:Rathbones soared 11% after a positive assets under management update, and happily just after my last monthly investment had gone through. My holding is now up by 19% and making £230 potential profit. I won't be buying any more for the time being.

POLR:Polar Capital also gave a very positive assets under management update and zoomed up 12% to take my holdings up 25% and 29% and making £936 potential profit, along with having received £293 in dividends.

CORE:Solidcore Resources has been creeping up at around 1% per week throughout the gold bull run, but this week they took off with a 13% rise. My holdings are still down 70% with a paper loss of £1,341 and I can't trade the shares unless they re-list in UK.

I was nervous about sacrificing my BOKU:Boku shares to buy back into CWR:Ceres Power following their 50% drop in share price, but I needn't have been. They went up another 25% this week to take my holding to 49% up with a £549 potential profit. That's much better than BOKU, although they are rising and I'd like to get back in if I get some cash.

Share of the Week is ASHM:Ashmore Group, which has languished in misery for years in my AJ Bell dealing account. A very positive assets under management update sent them up 26% this week. My holding is only 16% down and I plan to sell as soon as it gets to breakeven and take out the money to put towards my holiday. I've had £184 in dividends, so at breakeven I'll have made 13%.

Here's the ISA and shares portfolio after week 25 of year 11.

			Weekly Change
Cash	£91.44		-£4.10
Portfolio cost	£116,875.69		+£0
Portfolio sell value (bid price-commission)	£41,871.56	(-64.2%)	+£2,071.10
Potential profits	£1,059.59		+£405.25
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.76		+£0
Yr 11 Profit from sales	£527.06		+£0
Yr 11 proj avg monthly profit	£95.34	(1.3%)	-£4.71
Total Dividends	£12,557.43		+£0
Total Interest	£9.33		+£0
Total Profit from sales	£18,087.33		+£0
Average monthly cash profit	£238.86	(3.3%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Cash dropped due to monthly fees, a big leap in value, and potential profits up £405 mainly thanks to CWR:Ceres Power, but AMRQ:Amaroq went up 4% and TRU:Trufin 1% so they all contributed. 

Still an epic gap, but nice to see a tick up.

Well above the trend line now, but I've had blips like this in the past and they didn't last.

The SIPP looks like this after week 529 overall and week 9 of year 11.

			Weekly Change
Cash	£558.23		-£558.63
Portfolio cost	£148,529.18		+£1,331.86
Portfolio sell value (bid price - commission)	£89,924.00	(-39.5%)	+£2,565.24
Potential profits	£13,721.09		+£1,561.10
Yr 11 Dividends	£429.74		+£21.89
Yr 11 Interest	£6.07		+£0
Yr 11 Profit from sales	£2,298.10		+£754.08
Yr 11 proj avg monthly profit	£1,296.84	(16.3%)	+£256.22
Total Dividends	£18,649.94		+£21.89
Total Interest	£26.77		+£0
Total Profit from sales	£26,964.61		+£754.08
Average monthly cash profit	£360.26	(4.5%)	+£5.65

It's been a very busy week.

The main takeaway is that value is up by £2,565 and potential profits up £1,561 despite banking £754 in actual profits.

I had a £21 dividend from FSV:Fidelity Special Values.

First of all I had my regular monthly investments. They were 7 shares in III:3i Group at 3103p costing £219.80. They went up to 3359p by the end of the week. The other was 12 shares in RAT:Rathbones Group at 1996.7746p costing £242.31. Those were 2240p by the end of the week. That doesn't usually happen to me!

I wrote last week that I was concerned I had too many shares in CAML:Central Asia Metals, so I went through with my plan and sold 2,663 and kept 2,000. I sold them at 191.84p and made £754.08 (17.3%) profit, but liberated £5,096.

I wanted to keep as much of it in copper as possible, but if not copper then other metals.

First I bought 108 shares in ATYM:Atalaya Mining at 924.34p costing £1,010.24. That took my total holding to 224 shares at an average price of 895.52p costing £2,029.88 and making just £21 (1%) potential profit.

Next I bought another 25 shares in EDV:Endeavour Mining at 3994.8449p costing £1,015.65. That took my holding to 112 shares at an average price of 3757.13p costing £4,259.87. They are up by 5% and making £210.42 potential profit.

Next I increased my holding in RIO:Rio Tinto, buying 16 shares at 6174.199p costing £1,004.76. My total holding is now 132 shares at an average price of 5376.24p costing £7,203.82 and making £1,149.07 (16%) potential profit.

Next I bought another 176 shares in GGP:Greatland Resources at 621.08p costing £1,105.05. That takes my holding to 631 shares at an average price of 365.54p costing £2,330.49. They are making £1,619.61 (69%) potential profit.

My final purchase wasn't a metals company. I figured as this was mostly the profits from the CAML sale, I would get a new magic formula share. I bought 299 shares in SOI:Schroder Oriental Income at 357.78p costing £1,081.71. They had risen to 361.5p by the end of the week so are just £12.78 down due to commission.

The sale took my year 11 performance up to an impressive 16.3%, but this is only week 9, so if I sold nothing else this year it would only be 2.8%. I doubt I can keep up this momentum unless JLP:Jubilee Metals takes off. My long term performance remains at 4.5%.

This week the injection line stayed flat and the green line is getting very close. It's certainly much closer than it has been for several years.

A wonderful sight. Not far off getting back to where we were a year ago. This is most impressive given how low OPTI:Optibiotix is still.

I didn't think I could keep it above the trend line, but we're safe for a few more weeks.

A very busy week. I think I need a nice quiet one next week where nothing happens.

I've decided to refresh my magic formula rankings every 6 months, so I will do a complete refresh in February. My rule is that if something falls out of the top 50 and is in profit, I will sell it. Anything not in profit will be kept until it gets to break even and then sold. PSN:Persimmon is an example of that, sitting 79th in the ranking and only 3% down. In actual fact I've had £140 dividends so it's sort of 11% up, but I'll wait until it registers a true profit. I hope to sell that in the next few weeks.

Anything in the top 50 will be kept, but I will only purchase new shares if they are in the top 30. It will be interesting to see which companies get promoted into the top 30 in February. It usually takes me about 6 hours to enter all the data manually to re-calculate the ranking. I'll refresh the AIM one in February too. That takes a lot longer and will be done over a few weeks.

Week 544 Review - A superb week slightly spoiled by you guessed it - Optibiotix.

An excellent week thanks to JLP:Jubilee Metals having a bit of a spurt and SBTX:SkinBioTherapeutics going ballistic. The deficit between cost and value narrowed by £2,696 to £138,245 and the deficit between injection and value dropped to £55,474. Total portfolio value increased to £127,045 aided by a pension transfer injection.

The only big loser this week was OPTI:Optibiotix which fell 11% and reduced the week's gains by around £1,500. It seems odd that in a week it's shareholding in SBTX:SkinBioTherapeutics increased by almost £1 million, it still lost significant value. It's not surprising that despite having a vast amount of money to spend this week, not a penny of it went on OPTI.

ASHM:Ashmore Group went up 5% as my holding is now 33% down making loss of £333.

AMRQ:Amaroq went up 7% despite concerns that Trump might invade Greenland. Those concerns caused me to sell my SIPP holding, which I'm very annoyed about, but AMRQ is not a company that qualifies for my new SIPP rules so I should only hold it in my ISA.

EDV:Endeavour Mining ended up gaining by 6% but was up by double that until a pull-back on Friday. My holding is still up 4% and making £123 potential profit.

RAT:Rathbones rather frustratingly climbed 6% as I am buying my last tranche on Monday. My holding is up by 10% and making £92 potential profit.

SCT:Softcat has been sliding recently but staged an 8% recovery this week. My holding is still down by 8% and making a £102 loss.

TLOU:Tlou Energy went up 8%, but I think I will stop reporting on their movements. Although they are only 38% down, there are wild swings every week so I end up reporting on them every week. From now on I will only mention very significant moves.

JLP:Jubilee Metals continued a gradual improvement and went up 9%. Given my holding is very big, that accounted for a lot of the gains this week. I'm still around 50% down altogether, but some of my SIPP holdings that I intend to sell are now only 19% down.

CKN:Clarkson gave a positive trading statement and went up 10%, so my holding is now up 15% and making £180 potential profit.

FOUR:4imprint have had a huge turnaround and went up by 11% this week. I'm very glad I doubled my holding when their price crashed, as I reduced my average price from 5200p to 4084p and am now within £3 of going into profit.

GGP:Greatland Resources had yet another great week, increasing by 11% to go 110% up and making £1,349 potential profit.

AFC:AFC Energy seem to be popular again, and went up 12% this week. My holding is still 24% down and losing £501, but that's a much better place than before. 

CWR:Ceres Power is one of my very recent purchases after sacrificing BOKU:Boku last week to buy back in. It appears to have been well timed, as they went up by 17% this week, with my holding up by 19% and making £215 potential profit.

Share of the Week was SBTX:SkinBioTherapeutics, which zoomed up a massive 27%. My largest holding is now only 5% down making a £274 loss. I still hold some in my SIPP that I want to sell, but they are down by 40% so I need them to almost double before I can sell.

Here's the ISA and shares portfolio after week 24 of year 11.

			Weekly Change
Cash	£95.54		-£3.49
Portfolio cost	£116,875.69		+£0
Portfolio sell value (bid price-commission)	£39,800.46	(-65.9%)	+£2,252.70
Potential profits	£654.34		+£264.11
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.76		+£0
Yr 11 Profit from sales	£527.06		+£0
Yr 11 proj avg monthly profit	£100.05	(1.4%)	-£5.01
Total Dividends	£12,557.43		+£0
Total Interest	£9.33		+£0
Total Profit from sales	£18,087.33		+£0
Average monthly cash profit	£239.33	(3.3%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Nothing much happened, other than a big jump in value and an increase in potential profits of £264 as AMRQ:Amaroq and CWR:Ceres Power both went up significantly. Unfortunately TRU:Trufin dropped 3% else it would have been even better.

Nice, although the gap between injection and value is still vast and bigger than it was 12 months ago.

This might be the highest we've been above the trend line for a long while.

The SIPP looks like this after week 528 overall and week 8 of year 11.

			Weekly Change
Cash	£1,116.86		+£82.04
Portfolio cost	£147,197.32		+£3,393.27
Portfolio sell value (bid price - commission)	£86,026.90	(-41.6%)	+£443.37
Potential profits	£12,159.99		+£290.23
Yr 11 Dividends	£407.85		+£98.70
Yr 11 Interest	£6.07		+£5.93
Yr 11 Profit from sales	£1,544.02		+£743.28
Yr 11 proj avg monthly profit	£1,040.62	(13.1%)	+£365.92
Total Dividends	£18,628.05		+£98.70
Total Interest	£26.77		+£5.93
Total Profit from sales	£26,210.53		+£743.28
Average monthly cash profit	£354.61	(4.5%)	+£6.17

A lot happened this week.

First of all I sold my SIPP holding in AMRQ:Amaroq of 1,814 shares at 110.2p making £347.04 (21%) profit. I didn't really want to sell, but remember what happened to FXPO:Ferrexpo when Russia invaded Ukraine. I am keeping my ISA holding though. I wanted to stay in gold, and so invested in the biggest FTSE gold company EDV:Endeavour Mining. I added 52 shares at 3812.436p costing £2,004.33. That took my total holding to 87 shares at an average of 3688.82p costing £3,249 and making £123 potential profit.

Next I received my pension transfer, and as I had already planned what to do with it last week, I was able to invest it straight away. First I bought 75 shares in HSX:Hiscox at 1409.8872p costing £1,069.37. They dropped 1% from my purchase price by the end of the week.

I then bought 22 shares in MGNS:Morgan Sindall Group at 4724p costing £1,056.43. They climbed 4% by the end of the week and are already making £15 potential profit.

Lastly I bought 79 more shares in BPM:BP Marsh & Partners at 685.2p costing £553.26. That takes my holding to 228 shares at an average price of 692.39p which are 4% down and making a £64 loss.

CAML:Central Asia Metals has always been one of my favourite companies, and I bought big over the last year to make it one of my largest holdings. I am however becoming less enamoured with the current leadership. Their SASA zinc/lead mine is losing money, and their copper leaching at Kounrad only has about 4 more years to run. They got caught in a bidding war for an American copper company way outside their jurisdiction, halved the dividend, and are spending cash exploring for copper in Aberdeen. All of these are red flags, so I decided to significantly reduce my holding. 

First I sold 550 shares at 188.128p making £116.36 (12.6%) profit. I want to stick with copper so bought 116 shares in ATYM:Atalya Mining because they had recently dropped by 15% from an all-time high, and I've owned them before despite being 177th in my magic formula ranking. Copper is soaring so their profits should too. I bought them at 868.702p costing £1,019.64 and they went up 2% by the end of the week and are almost in profit.

The next day RIO:Rio Tinto announced they were merging with GLEN:Glencore and the price dropped. I've recently increased my holding in RIO and saw this as an opportunity, so sold another 1,100 CAML shares at 190.2413p making £279.87 (15.4%) profit. I bought 33 shares in RIO at 6107.4985p costing £2,037.50. That takes my RIO holding to 116 shares at an average price of 5266.18p costing £6,199. They are up by 12% making £761 potential profit and have paid £185 dividends.

As a result of taking £743 profit, the increase in value was only £443, and I have far less JLP:Jubilee Metals and SBTX:SkinBioTherapeutics in my SIPP. The sales did push Year 11 projected profits to 13%, but we are only on week 8 so I doubt I'll keep it up. Long term profit didn't budge at 4.5%, but that's based on percentage of portfolio injection amount, which went up £2,400 this week.

I got £5 interest from AJ Bell and £98 dividend from POLR:Polar Capital.

The green line is definitely chasing the orange, even though orange is trying to run away. Crossing that line would be a huge morale boost.

Less impressive as we're not much higher than last week, but still well above the trend line.

Enough profit to keep us above the trend line, but how long can I keep that up?

So, I still have 5,140 shares in CAML:Central Asia Metals in my SIPP costing £8,528 and I reckon I want to get it down to only holding £3,000 worth of shares. That gives my £5,500 to play with over the next few weeks. My AJ Bell holding is only 2% down and will liberate around £900 if I sell them when they get to break even. I need that to allow myself another 4 months of regular investments. The rest are in my Hargreaves Lansdown account where I can't use the proceeds for regular investments so need to re-invest.

I should definitely keep it in copper, but have already bought as much RIO:Rio Tinto as I want. However I may buy some more if the price drops again. I may buy some more ATYM:Atalya Mining, but should I consider ANTO:Antofagasta given they are ranked 224 on my magic formula list and are at what appears to be a very high valuation. I think not. The other option is to move it to gold.

I think I'll retain it in CAML until I get an opportunity to buy something cheap. That strategy does rely on CAML continuing to rise, but I don't see copper dropping any time soon.

Week 543 Review - Jubilee Metals gives a very happy end to 2025 and start of 2026.

It was looking like a brilliant week, with nearly everything in the black, until Friday when nearly everything went into the red. However, a socking great rise in JLP:Jubilee Metals meant the deficit between cost and value narrowed by £4,225 to £140,941 and the deficit between injection and value reduced to £58,997, with total portfolio value increasing to £120,871.

Worst performer was EDV:Endeavour Mining which dropped 7% despite gold hardly dropping at all. These are barely in profit, which is a worry if gold has peaked. I'm hoping they will announce big profits and start paying a dividend, which should lead to a re-rate.

TLOU:Tlou Energy dropped 6% but there's nothing unusual in that.

ALU:Alumasc Group has been dropping quite badly over the last few months, but recovered 6% this week to go 25% up.

YU.:Yu Group also rose 6% and are almost in profit.

IES:Invinity Energy announced some new contracts and went up 8%, so my recent purchase is only 10% down but my main holding is 89% down.

AMRQ:Amaroq went up a healthy 10% to go 27% up, but I'm getting increasingly nervous about the intentions of America towards Greenland, and I'm not sure I'm prepared to risk the same fate as POLY:Polymetal and FXP:Ferrexpo which lost almost everything when Putin invaded Ukraine, as I can see similar happening to AMRQ. I might sell the ones in my SIPP but keep the ones in my ISA because they have massive potential if Greenland is left alone.

JLP:Jubilee Metals announced the completion of the sale of South African assets, which was a relief as I was concerned something would mess that up. However now they are certain of the cash, I'm hoping it won't be long before announcements of new tailings purchases. My holdings are still around 50% down, so a long way to break even.

Share of the week is SBTX:SkinBioTherapeutics which went up 18%. I think the recent drops were caused by some big sellers, so hopefully now they have gone, potential investors are considering the potential of the new compound going into products and revenue coming in.

Here's the ISA and shares portfolio after week 23 of year 11.

			Weekly Change
Cash	£99.03		-£78.09
Portfolio cost	£116,875.69		+£117.60
Portfolio sell value (bid price-commission)	£37,547.76	(-67.9%)	+£2,991.04
Potential profits	£390.23		+£150.78
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.76		+£0.01
Yr 11 Profit from sales	£527.06		+£39.50
Yr 11 proj avg monthly profit	£105.06	(1.4%)	+£3.01
Total Dividends	£12,557.43		+£0
Total Interest	£9.33		+£0.01
Total Profit from sales	£18,087.33		+£39.50
Average monthly cash profit	£239.80	(3.3%)	-£0.12
(Sold stocks profit + Dividends - Fees / Months)

I looked at the price of CWR:Ceres Power and noticed it had dropped back below the price I bought it before selling for a profit. It appears to have been the victim of a bear attack from someone presumably shorting the shares. They've engineered a 50% drop in price, so I think now would be a good time to buy back. 

I sacrificed my holding in BOKU:Boku as it wasn't really going anywhere. I may buy back if I make any profits elsewhere, but I thought there was a better potential in CWR. I sold my 495 shares in BOKU at 212p making £39.50 (3.9%) profit. Not a lot, but still a profit. I bought 538 shares in CWR at 206.681p costing £1,122.50. Happy to say they were up 3% on my purchase price and £19 in profit by the end of the week.

Value was up by almost £3,000 thanks to the big rises in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and potential profits rose £150 mainly thanks to AMRQ:Amaroq.

The first time in a very, very long time we've had a good size tick upwards in one week.

Soaring above the trend line

Too small a profit to make any difference.

The SIPP looks like this after week 527 overall and week 7 of year 11.

			Weekly Change
Cash	£1,034.82		+£36.19
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£82,190.26	(-42.8%)	+£1,234.65
Potential profits	£11,869.76		+£218.91
Yr 11 Dividends	£309.15		+£36.05
Yr 11 Interest	£0.14		+£0.14
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£674.70	(8.7%)	-£86.31
Total Dividends	£18,529.35		+£36.05
Total Interest	£20.84		+£0.14
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.44	(4.5%)	-£0.37

I had a £36 dividend from INVP:Investec, a more modest increase in value due to smaller holdings in JLP:Jubilee Metals and SBTX:SkinBioTherapeutics, and a decent increase in potential profits of £218 mainly thanks to ALU:Alumasc Group and AMRQ:Amaroq.

I like that graceful glide up towards the injection line.

Nicely above the trend line, but is it just a short-lived Santa Rally?

We're on the trend line. Selling my SIPP AMRQ:Amaroq should keep me above it next week.

I think I'm pretty much decided on selling my SIPP holding in AMRQ:Amaroq. It doesn't qualify as a SIPP holding because it doesn't pay dividends and isn't on my magic formula ranking. Selling at Friday's close price will get me £288 (17%) profit and liberate £1,929. It's in my Hargreaves Lansdown account, which is about to get £2,400 transfer from my pension and has £300 cash, so I'll have around £4,700 to invest in one go.

It's a shame HL doesn't allow regular investments from cash balance - it only allows them via direct debit, with the new injection invested each month. AJ Bell is much better as you can set up regular investments on the cash balance. When I sell an AJ Bell share, I leave it as cash so the regular investments have a pot to use.

I should really re-invest at least some of the proceeds in gold stocks, but there are few suitable candidates. CMCL:Caledonia Mining are 115th in my magic formula ranking and have always done badly for me. They are racking up big debt for a new mine and having to sell a load of gold using Zimbabwe currency so there are too many red flags. EDV:Endeavour Mining are 138th in my magic formula ranking, but they are massively increasing both production and free cash flow, reducing debt rapidly and paying dividends, so given my holding is only up 2% due to a recent pull-back, maybe I should put all AMRQ:Amaroq proceeds there.

Meanwhile I'll continue with my original plan to invest £1,100 in both HSX:Hiscox and MGNS:Morgan Sindall, and use the rest to increase my holding in BPM:BP Marsh & Partners. It's nice to have a plan!

Week 542 Review - A good week for Christmas

A nice positive week for Christmas. Very little happened, but most of it was positive. The deficit between cost and value narrowed by £1,204 to £145,167, and the deficit between injection and value decreased to £63,357. Total portfolio value went up to £116,511.

Only big loser was PBX:Probiotix Health which dropped 0.5p which is 7%. A continued drift downwards after spiking briefly a few months ago.

SBTX:SkinBioTherapeutics recovered from recent drops to go up 8% but is still a long way down.

Share of the Week is PAF:Pan African Resources, which also climbed 8% but has now gone 296% up. My biggest ever profit margin for a share. I slightly regret taking some profits, but I did it to spread my gold risk to some other holdings, most of which are also doing well. I don't want to sell any more.

Here's the ISA and shares portfolio after week 22 of year 11.

			Weekly Change
Cash	£177.12		+£50.00
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,439.12	(-70.5%)	+£110.18
Potential profits	£239.45		+£46.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£102.05	(1.4%)	-£4.86
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£239.92	(3.3%)	-£0.45
(Sold stocks profit + Dividends - Fees / Months)

The rise in SBTX:SkinBioTherapeutics countered the drop in PBX:Probiotix Health and all three profitable shares went up a little, but most things remained flat, so very little change in value. Cash went up £50 thanks to an injection to my share account to cover fees.

Flat.

Still pretty much on the trend line.

The SIPP looks like this after week 526 overall and week 6 of year 11.

			Weekly Change
Cash	£998.63		+£121.50
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£80,955.61	(-43.7%)	+£1,094.74
Potential profits	£11,650.85		+£1,170.97
Yr 11 Dividends	£273.10		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£\800.74		-£0
Yr 11 proj avg monthly profit	£913.22	(9.9%)	-£152.21
Total Dividends	£18,493.30		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.81	(4.5%)	-£0.66

Cash went up £121 thanks to tax rebates, and most magic formula shares went up so both value and potential profits went up by just over £1,000. Nothing else happened.

Is it my imagination or is the gap to injection actually narrowing?

A satisfying gap above the trend line.

I guess it was inevitable that the trend line would catch up at some point. It was always going to be difficult to maintain that performance. I don't want to sell good shares to try and maintain the rise. JLP:Jubilee Metals could fix that if they just sort themselves out.

I've transferred £2,300 out of my work pension into my SIPP which should arrive either next week or more likely the week after. Currently I'm planning on buying HSX:Hiscox and MGNS:Morgan Sindall to add to my magic formula collection, unless either spikes before then.

Week 541 Review - Great week for the SIPP, flat for the ISA.

A good week for my SIPP, and a flat week for my ISA. A mini Santa Rally saw the deficit between cost and value narrow by £1,299 to £146,372 and the deficit between injection and value reduce to £64,625. Total portfolio value increased to £115,194.

Worst performer was AFC:AFC Energy which dropped 9%, which I suspect was profit taking after the recent big rise. Unfortunately my holding is now back to 32% down making a £667 loss.

TRU:Trufin dropped 5% for no clear reason and my holding is now only 5% up making £48 potential profit.

It was all good news after that.

BOKU:Boku had slid into loss over the last few weeks, but went up 5% and is just in profit by £4.

III:3i Group was a new purchase last week and went up 5% to go 7p into profit. I don't really want them to climb too quickly as I have another 4 months of buying with my monthly investment.

INVP:Investec had slid a bit recently but recovered 5% to go just 3% down making a £37 loss.

IES:Invinity Energy announced some new projects that have been delivered and went up 6%. My recent purchase is down 17% making £52 loss but my old holding is still 90% down making £1,174 loss..

PRU:Prudential has been on a great run and climbed another 7% this week to go 17% up and making £179 potential profit.

RAT:Rathbones also went up 7% and has gone into profit by 3% making £25 potential profit.

EDV:Endeavour Mining had a good week on an increasing gold price, rising 9% and going 8% up and making £96% profit.

Share of the Week is GGP:Greatland Resources which went up 10% and is now 86% up and making £1,059 potential profit.

Here's the ISA and shares portfolio after week 21 of year 11.

			Weekly Change
Cash	£127.12		+£0
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,328.94	(-70.6%)	-£83.51
Potential profits	£192.98		-£53.47
Yr 11 Dividends	£69.36		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£106.91	(1.5%)	-£5.34
Total Dividends	£12,557.43		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.37	(3.3%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

Virtually nothing happened. All my big holdings were flat and the £53 drop in potential profits was all TRU:Trufin.

Sticking to that pesky trend line.

The SIPP looks like this after week 525 overall and week 5 of year 11.

			Weekly Change
Cash	£877.13		+£74.23
Portfolio cost	£143,804.05		+£0
Portfolio sell value (bid price - commission)	£79,860.87	(-44.5%)	+£1,382.60
Potential profits	£10,479.88		+£1,043.42
Yr 11 Dividends	£273.10		+£74.23
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£913.22	(11.8%)	-£147.89
Total Dividends	£18,493.30		+£74.23
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.47	(4.5%)	-£0.06

Cash went up £74 thanks to a £32 dividend from N91:Ninety One, £13 from SCT:Softcat and £18 from YU.:Yu Group. Most of the £1,382 rise was in profitable shares, so potential profits increased by £1,043, and having those dividends is helping maintain my long term performance. It would be great to get to a stage where I have enough dividend-paying shares to have 4.5% return without needing to sell anything.

The gap to injection is narrowing. It would be so good to cross that line.

A definite tick up above the trend line.

Still just above the trend line but it's catching up.

Nice to have a positive week just before Christmas. There will be a few trading days next week so lets hope it continues.

Week 540 Review - Record deficit between cost and value a poor Christmas present

A pretty bad week across much of the portfolio, and a new record low. Thankfully some decent rises offset the big drops in some of my key holdings. The deficit between cost and value widened by £584 to a new high of £147,671, and the deficit between injection and value rose to £65,998. Total portfolio value fell to £113,820.

The worst performer was my largest holding OPTI:Optibiotix, which dropped 1p and lost over £2,000  in value, so the fact the weekly drop was only £584 shows how well some other shares did.

SBTX:SkinBioTherapeutics is another of my biggest holdings and dropped 12% probably due to one large shareholder having sold out.

ALU:Alumasc Group dropped 8% for no reason but my holding is still 20% up overall. They have had a pretty massive fall over the last few months, with shareholders worried about increasing costs and potentially smaller profits. I've re-calculated my magic formula rankings based on their recent performance and they drop to 28th, but that's still in the top 50, so I'll only sell if they drop outside that.

AMP:Ampeak Energy dropped 7% for no obvious reason.

FDM:FDM Group continue to slide after I thought they were staging a recovery, but they fell 6% this week to go 60% down.

POLR:Polar Capital were having a great run, but it seems to be over, with a drop of 5% this week leaving my holding only just in the black.

AMRQ:Amaroq released amazing drilling results, but only managed to climb 5%, but that was enough to put my SIPP holding back into profit and my ISA holding is 14% up.

TLOU:Tlou Energy continue to yo-yo and went up 6% this week.

TRU:Trufin climbed 6% and are now 10% up in my ISA.

AFC:AFC Energy continue to surge, with another 7% gain this week leaving my holding only down 26%.

FXPO:Ferrexpo is another yo-yo stock that would be great for trading. They went up 8% this week so my holding is now 85% down.

GGP:Greatland Resources had a splendid week, climbing 13% to go 69% up overall.

Share of the Week is PBX:Probiotix Health which went up 17% and is now 66% down. I suspect that the person selling a big chunk of SBTX:SkinBioTherapeutics may have put it here and caused a short term blip, as there's no sign of longer term price support.

Here's the ISA and shares portfolio after week 20 of year 11.

			Weekly Change
Cash	£127.12		+£40.01
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,412.45	(-70.5%)	-£378.99
Potential profits	£246.45		+£128.94
Yr 11 Dividends	£69.36		+£44.04
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£112.25	(1.5%)	+£3.21
Total Dividends	£12,557.43		+£44.04
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.81	(3.3%)	-£0.13
(Sold stocks profit + Dividends - Fees / Months)

I got a £44 dividend from ASHM:Ashmore Group minus monthly fees from AJ Bell. Potential profits are up £128 thanks to AMRQ:Amaroq and TRU:Trufin both having good weeks and despite BOKU:Boku sliding to a loss. The drop in portfolio value was pretty small all things considered.

Not the bounce I was hoping for as we lead into Christmas

Staying on the trend line

The SIPP looks like this after week 524 overall and week 4 of year 11.

			Weekly Change
Cash	£802.90		-£547.47
Portfolio cost	£143,804.05		+£707.67
Portfolio sell value (bid price - commission)	£78,478.27	(-45.4%)	-£205.29
Potential profits	£9,436.46		+£525.56
Yr 11 Dividends	£198.87		+£163.67
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,061.11	(13.7%)	-£122.30
Total Dividends	£18,419.07		+£163.67
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£349.53	(4.5%)	+£0.66

I did my monthly investments. First I continued buying RAT:Rathbones. I bought 13 shares at 1821p costing £239.41. Unfortunately they promptly dropped to 1780p so my timing wasn't great. I have one more month of buying RAT.

Next I added to my position in SCT:Softcat as I think the recent drop is unjustified. I bought 17 shares at 1423.9255p costing £244.78. I'll buy more next month if they continue to remain depressed.

Finally I bought back into III:3i Group after their recent share price collapse, as I think it was over-done. It does however mean I was right to sell them when I suspected they were over valued. I bought 7 shares at 3155.497p costing £223.48.

I had an impressive £163 in dividends, made up of £49 from JHD:James Halstead, £12 from KNOS:Kainos Group and £102 from PAF:Pan African Resources.

Potential profits went up by £525 because many profitable shares had a good week, and that reduced the losses from the big fallers to just £205.

The gap to injection has been remarkably constant, but isn't improving.

Fractionally above the trend line

Again just above the trend line.

If there's going to be a Santa rally then it needs to be next week, but I can't see where it's going to come from. I only have enough cash in my SIPP to do one more month of multiple regular investments. I'd love to be able to boost that pot before 10th February else I'll have to go back to just the one monthly purchase from my regular savings.

News came through that my DDDD:4D Pharma shares are officially worthless and they have been cancelled. I was holding out a tiny hope they'd get something for selling the IP, but it at least ends the chapter of my worst ever investment, losing £18,600. That disaster is going to impact my performance for a long time to come, and I know it won't be the last as TRX:Tissue Regenix will be dead very soon, as will KIBO:Kibo Energy, and between them they will lose me £6,000. If OPTI:Optibiotix goes bust then I may as well give up.

Week 539 Review - A down week overall although SIPP up slightly.

A down week due to a big drop in the ISA, although the SIPP was in the black. The deficit between cost and value widened by £483 to £147,087 and the deficit between injection and value widened to £65,614. Total portfolio value dropped to £114,204.

Worst performer was IPX:Impax Asset Management which dropped 14% after final results. I don't understand, as the share price was massively hammered when they lost the St James's Place contract, and the figures were based on no longer having that contract, so they have been hammered twice for the same news. My main holding is now down 67% and my recent purchase is already down 22%.

SBTX:SkinBioTherapeutics results were predictably hopeless and the share price dropped by 11% back to where it was before a recent steady climb.

TLOU:Tlou Energy dropped 10% in the usual massive yo-yo.

BOKU:Boku dropped 8% for no obvious reason and have now slipped to a 2% loss.

PAF:Pan African Resources had a good week, climbing 6% to go 247% up.

GGP:Greatland Resources also had a good week, climbing 8% to go 49% up.

Share of the week is AFC:AFC Energy which climbed 10% and my holding is now only 37% down, which is significantly better than just a few weeks ago. A respected pundit has tipped them as a potential 10-bagger which helped. I hope he's right.

Here's the ISA and shares portfolio after week 19 of year 11.

			Weekly Change
Cash	£87.11		-£3.75
Portfolio cost	£116,758.09		+£0
Portfolio sell value (bid price-commission)	£34,791.44	(-70.2%)	-£919.49
Potential profits	£117.51		-£81.38
Yr 11 Dividends	£25.32		+£0
Yr 11 Interest	£0.75		+£0
Yr 11 Profit from sales	£487.56		+£0
Yr 11 proj avg monthly profit	£109.04	(1.5%)	-£6.96
Total Dividends	£12,513.39		+£0
Total Interest	£9.32		+£0
Total Profit from sales	£18,047.83		+£0
Average monthly cash profit	£240.94	(3.3%)	-£0.47
(Sold stocks profit + Dividends - Fees / Months)

Cash went down due to ISA fees, and big drop in value thanks to JLP:Jubilee Metals and SBTX:SkinBioTherapeutics.  With none of my profitable shares increasing and BOKU:Boku having a big drop, potential profits fell by £81.

The slide continues

Sticking with that trend line

The SIPP looks like this after week 523 overall and week 3 of year 11.

			Weekly Change
Cash	£1,350.37		+£233.34
Portfolio cost	£143,096.38		+£0
Portfolio sell value (bid price - commission)	£77,975.89	(-45.5%)	+£436.00
Potential profits	£8,910.90		+£1,009.88
Yr 11 Dividends	£35.20		+£0
Yr 11 Interest	£0		+£0
Yr 11 Profit from sales	£800.74		+£0
Yr 11 proj avg monthly profit	£1,183.21	(15.3%)	-£627.80
Total Dividends	£18,255.40		+£0
Total Interest	£20.70		+£0
Total Profit from sales	£25,467.25		+£0
Average monthly cash profit	£348.87	(4.5%)	-£0.80

Cash increased due to the arrival of my £250 monthly investment money, minus monthly SIPP fees. Value increased by £436 despite some big drops, and potential profits went up by over £1,000 thanks to a 4% rise in CAML:Central Asia Metals, 4% for KNOS:Kainos Group and the big rises in GGP:Greatland Resources and PAF:Pan African Resources.

Year 11 projected performance is skewed by last week's sale, so will drop dramatically over the next few weeks. TRX:Tissue Regenix announced they are de-listing and granting an epic number of shares to an existing investor to bail them out, which will make my shares utterly worthless. I'll lose £3,437 which will hammer my year 11 and long term performance, so I really need to sell enough to make £2,600 profit to balance out the loss for year 11. I'm reluctant to lose some of my more profitable shares though, so I may just take the hit for now and hope JLP:Jubilee Metals sorts itself out so I can plug the gap.

Great to see that gap closing, but very slowly.

Just above the trend line.

This is going to be ruined when I recognise the TRX:Tissue Regenix loss.

So, this first week in December has failed to deliver a Santa rally as my portfolio has dropped in value. At the moment I can't see where any rally is going to come from, as my biggest holdings are still drifting downwards. At least CAML:Central Asia Metals is staging a bit of a recovery as that's my 4th biggest holding. RIO:Rio Tinto is my 6th biggest, and that's now in profit and sneaking up too. Unfortunately OPTI:Optibiotix, JLP:Jubilee Metals and PBX:Probiotix Health are my top 3 and they are utterly hopeless, and SBTX:SkinBioTherapeutics is 5th and that is going downwards.